Commission Delegated Regulation (EU) 2020/689Dangos y teitl llawn

CHAPTER 4 U.K. Member State or zone free from infection with BTV

Section 1 U.K. Granting of the status

1. The status free from infection with BTV may only be granted to a Member State or to a zone, where BTV has never been reported, if: U.K.

(a)

surveillance in accordance with Section 1 of Chapter 1 has been conducted at least for the past 24 months; and

(b)

no case of infection with BTV has been confirmed during the past 24 months in the targeted animal population.

2. The status free from infection with BTV may only be granted to a Member State or to a zone where BTV has already been reported if: U.K.

(a)

surveillance in accordance with Section 3 of Chapter 1 has been conducted at least for the past 24 months; and

(b)

no case of infection with BTV has been confirmed during the past 24 months in the targeted animal population.

Section 2 U.K. Maintenance of the status

1. The status free from infection with BTV may only be maintained if: U.K.

(a)

the requirements laid down in point 1 of Section 1 are complied with; and

(b)

animals and germinal products from the targeted animal population are only moved into or through the Member State or zone when the requirements laid down in Articles 43 and 45 are complied with.

2. The intensity and frequency of the surveillance referred to in point 1 of Section 1 must be duly adapted to: U.K.

(a)

the health status of neighbouring Member States, zones or third countries in accordance with point 3 of Section 4 of Chapter 1;

(b)

the introduction of animals from the targeted animal population that may have jeopardised the health status of the Member State or zone, in accordance with point 6 of Section 4 of Chapter 1.

3. If no circulation of the infection has been detected for 2 consecutive years following granting of the status free from infection with BTV of a Member State or of a zone, surveillance must be based on: U.K.

(a)

random annual surveillance at least to detect, with a 95 % level of confidence, the infection with BTV at a target prevalence rate of 20 %; or

(b)

risk-based annual surveillance to detect infection with BTV carried out taking into account the systems of production and the risk factors identified.